Steritalc Powder
FDA Label NDC 62327-444

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Novatech Sa for the product Steritalc (NDC 62327-444). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding highlights of prescribing information, indications and usage, dosage and administration, dosage forms and strengths, contraindications, warnings and precautions, adverse reactions, use in specific populations, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.